PM360 Announces 2025 Lifetime Achievement Award winner
Recipient to be honored at Trailblazer Award Gala at NYC's Gotham Hall,
PM360—a leading life sciences marketing industry trade publication—established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.
"
Currently,
In addition to his professional accomplishments,
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Contact:
646-300-8113
[email protected]
646-300-8114
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/pm360-announces-2025-lifetime-achievement-award-winner-302489979.html
SOURCE PM360
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- World's First Autonomous Humanoid Tennis Match: GALBOT Robots Complete 100+ Consecutive Rallies
- HTX Research Examines U.S. AI Equities: Technology Remains Early, While Capital Expenditure and Valuations Have Entered the Late Cycle
- Latest Crypto News: Apeing’s Upcoming Presale Hype Joins Tron and Cardano’s Rising Activity
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
AdComSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share